Search Videos and More


Breast Cancer Screening Guidelines: What You Should Know Video

Breast Cancer Screening Guidelines: What You Should Know

Watch this short video on the three components of breast cancer screening—brought to you by Andrea Porpiglia, MD, MSc, FACS, Assistant Professor, Department of Surgical Oncology at Fox Chase.
Adjuvant Olaparib a Win for High-Risk, BRCA-Mutant Early Breast Cancer News

Adjuvant Olaparib a Win for High-Risk, BRCA-Mutant Early Breast Cancer

Researchers at Fox Chase Cancer Center discuss the benefits of the PARP inhibitor olaparib for women with high-risk, HER2-negative, BRCA-mutant early breast cancer.
19th Annual San Antonio Breast Cancer Symposium Symposium

19th Annual San Antonio Breast Cancer Symposium

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this virtual CME is designed to help medical, radiation and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2020 San Antonio Breast Cancer Symposium into practice.
Fox Chase Becomes First Cancer Center in the Northeast to Utilize New Surgical Navigation Technology for Breast-Conserving Surgeries News

Fox Chase Becomes First Cancer Center in the Northeast to Utilize New Surgical Navigation Technology for Breast-Conserving Surgeries

Fox Chase Cancer Center is the first cancer center in the Northeast to feature a new tumor marker technology—the EnVisio Surgical Navigation System and SmartClip Soft Tissue Marker technology. This advancement will make breast excisional biopsies and breast-conserving surgeries more precise.
Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials News

Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials

Recognizing the need for further evaluation of immunotherapy for breast cancer treatment, Fox Chase Cancer Center has opened two investigator-initiated trials exploring the use of immunotherapy for triple-negative and HER2-positive breast cancer.